Pacira Pharmaceuticals buy Raymond James
Start price
31.07.24
/
50%
€19.10
Target price
31.07.25
€34.20
Performance (%)
0.00%
Price
30.07.24
€17.90
Summary
This prediction is currently active. Raymond_James's BUY prediction for Pacira Pharmaceuticals is currently unchanged. This prediction currently runs until 31.07.25. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Pacira Pharmaceuticals | 0.00% |
iShares Core DAX® | 0.786% |
iShares Nasdaq 100 | 1.855% |
iShares Nikkei 225® | 3.947% |
iShares S&P 500 | 1.787% |
Comments by Raymond_James for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target lowered by analysts at Raymond James from $41.00 to $37.00. They now have an "outperform" rating on the stock.
Ratings data for PCRX provided by MarketBeat
Stopped prediction by Raymond_James for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€29.60
20.12.23
20.12.23
€38.31
20.12.24
20.12.24
-35.47%
30.07.24
30.07.24